With the analysis among 2,372 patents, we discovered top 437 key players by total patent application. Eli Lilly & Co., Cumberland Pharmaceuticals, Inc., Theravance Biopharma Antibiotics IP LLC are dominant in this area. They take 16.69% of the total patent filing.
Indiana, United States
Patent: 240
Cumberland Pharmaceuticals, Inc.
Tennessee, United States
Patent: 79
Theravance Biopharma Antibiotics IP LLC
Delaware, United States
Patent: 77
California, United States
Patent: 63
Xellia Pharmaceuticals ApS
Hovedstaden, Denmark
Patent: 62
Osaka-fu, Japan
Patent: 58
California, United States
Patent: 34
Ohio, United States
Patent: 33
Tokyo-to, Japan
Patent: 33
Novartis Vaccines & Diagnostics, Inc.
New Jersey, United States
Patent: 33
With the analysis among 86 patents, we discovered top 9 start-ups by total patent application. Venn Biosciences Corp., SyntheX, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
California, United States
Patent: 34
California, United States
Patent: 21
Institut National de la Santé et de la Recherche Médicale
Vaud, Switzerland
Patent: 8
Massachusetts, United States
Patent: 6
California, United States
Patent: 2
Somerset Therapeutics LLC
New Jersey, United States
Patent: 2
Sachsen, Germany
Patent: 1
New York, United States
Patent: 1
With the analysis among related 669 patents applied in the last 5 years. We discover 257 most active companies in this area. The fast-growing Venn Biosciences Corp., Insmed, Inc., Max Planck Gesellschaft zur Förderung der Wissenschaften eV take 12.86% of patent filing during this period.
California, United States
Patent: 34
New Jersey, United States
Patent: 27
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Bayern, Germany
Patent: 25
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 24
Dalian Institute of Chemical Physics Chinese Academy of Sciences
Liaoning Sheng, China
Patent: 21
Ohio, United States
Patent: 16
Ningxia Tianren Wolfberry Biotechnology Co., Ltd.
Ningxia Huizi Zizhiqu, China
Patent: 13
Ningxia Qi Peptide Technology Co., Ltd.
Ningxia Huizi Zizhiqu, China
Patent: 11
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 10
DH Technologies Development Pte Ltd.
Central Singapore, Singapore
Patent: 10
With the analysis among related 669 patents in last 5 years, we discover 177 new entrants. Venn Biosciences Corp., Max Planck Gesellschaft zur Förderung der Wissenschaften eV, Regeneron Pharmaceuticals, Inc. are the most active new entrants in this area.
California, United States
Patent: 34
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Bayern, Germany
Patent: 25
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 24
Ningxia Qi Peptide Technology Co., Ltd.
Ningxia Huizi Zizhiqu, China
Patent: 11
Jiangsu Sheng, China
Patent: 8
Tangshan Peptide Jingtang Biotechnology Co., Ltd.
Hebei Sheng, China
Patent: 8
Vaud, Switzerland
Patent: 8
Hano Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 5
Beijing Academy of Agriculture & Forestry Sciences
With the analysis among 1,087 patents, we discovered top 155 universities and scientific research institutions by total patent application. Dalian Institute of Chemical Physics Chinese Academy of Sciences, Fudan University, Hokkaido University are dominant in this area. They take 18.22% of the total patent filing.
Dalian Institute of Chemical Physics Chinese Academy of Sciences
Liaoning Sheng, China
Patent: 53
Shanghai Shi, China
Patent: 25
Hokkaido, Japan
Patent: 23
The Scripps Research Institute
California, United States
Patent: 18
New Jersey, United States
Patent: 15
Texas, United States
Patent: 13
The University of Queensland
Queensland, Australia
Patent: 12
Hovedstaden, Denmark
Patent: 11
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 11
Western University of Health Sciences
California, United States
Patent: 11